This week we highlight changes in drug exclusivity, international mRNA manufacturing expansion, clinical trial challenges in Russia, and recent Food and Drug Administration activities. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Top 10 ... READ MORE >
Health care
Along with community benefits, ESG efforts could reduce capital costs for health care providers
Health care executives and treasury departments may meaningfully engage in environmental, social and governance finance this year as we see ESG bonds and loans helping hospitals and health systems reduce capital costs in exchange for providers improving the health of their local communities—something they ... READ MORE >
5 things to know in life sciences: Week of Feb. 28, 2022
This week we highlight clinical holds on cell and gene therapies, clinical trials and patient experience, artificial intelligence and identifying bone fractures, and more. Each week we highlight five things you need to know about in the life sciences industry. Here’s the latest. Cell and gene therapies ... READ MORE >
5 things to know in life sciences: Week of Feb. 21, 2022
This week we highlight a personalized blood testing company, an artificial intelligence-based software platform capable of detecting heart disease and a promising mRNA technology that can heal bone defects. In addition, we look at a novel company providing a kidney care solution as well as Nintendo and ... READ MORE >
5 things to know in life sciences: Week of Feb. 14, 2022
This week, we highlight Moderna’s contract extension with Rovi, a recent report that indicates the global contract development and manufacturing organization (CDMO) market is expected to grow by over $8.65 billion by 2026, Robert Califf’s return as Food and Drug Administration commissioner, an artificial ... READ MORE >
5 things to know in life sciences: Week of Feb. 7, 2022
This week we highlight regulatory challenges for the United States and China; a softening of guidelines in the prescription of opioids; and record-breaking sales figures for Pfizer as it sees a more than 600% increase in vaccine revenue. Finally, we look at a new cartilage implant inspired by spiders and ... READ MORE >
5 things to know in life sciences: Week of Jan. 31, 2022
This week, we highlight a breakthrough tubeless insulin pump which received Food and Drug Administration clearance. We also look at a telehealth pharmacy booming during the pandemic, potential breakthroughs in neurovascular research, the disparity of Asian scientists’ contributions and recognition in ... READ MORE >
ESG’s growing impact on the health care industry: Spring 2022 outlook
Aside from the obvious benefits to community, culture and environment, another reason health care organizations are focused on ESG is to attract financing. Health care organizations will likely begin measuring and reporting ESG data as an evaluation tool for investors. Read about other outlook ... READ MORE >
Persistent labor shortages will challenge most health care providers: Spring 2022 outlook
The health care ecosystem continues to struggle with a depressed labor supply, a situation unlikely to abate in the near term. Health care organizations will be forced to explore new technology solutions to fill the human labor gap. Technologies like robotic process automation and descriptive ... READ MORE >
Cybersecurity risks and challenges in health care: Spring outlook 2022
Given the risks and costs associated with cyberthreats, health care information security should be of utmost importance for organizational leadership. To fortify cybersecurity efforts, health care providers and organizations should consider the following measures: general risk analysis, remote ... READ MORE >